Review
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 26, 2023; 11(15): 3369-3384
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3369
Superior mesenteric artery syndrome: Diagnosis and management
Akihiko Oka, Muyiwa Awoniyi, Nobuaki Hasegawa, Yuri Yoshida, Hiroshi Tobita, Norihisa Ishimura, Shunji Ishihara
Akihiko Oka, Nobuaki Hasegawa, Norihisa Ishimura, Shunji Ishihara, Department of Internal Medicine II, Shimane University Faculty of Medicine, Izumo 693-8501, Shimane, Japan
Muyiwa Awoniyi, Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgery Institute, Hepatology Section, Cleveland Clinic, Cleveland, OH 44195, United States
Yuri Yoshida, Clinical Laboratory Division, Shimane University Hospital, Izumo 693-8501, Shimane, Japan
Hiroshi Tobita, Division of Hepatology, Shimane University Hospital, Izumo 693-8501, Shimane, Japan
Author contributions: All the authors solely contributed to this paper; Oka A, Awoniyi M, Hasegawa N, and Yoshida Y drafted the manuscript; Tobita H, Ishimura N, and Ishihara S are the supervisors of study.
Conflict-of-interest statement: All authors have no conflict-of-interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Akihiko Oka, MD, PhD, Assistant Professor, Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Izumo 693-8501, Shimane, Japan. aoka@med.shimane-u.ac.jp
Received: December 29, 2022
Peer-review started: December 29, 2022
First decision: February 2, 2023
Revised: February 13, 2023
Accepted: April 18, 2023
Article in press: April 18, 2023
Published online: May 26, 2023
Processing time: 147 Days and 6 Hours
Abstract

Superior mesenteric artery (SMA) syndrome (also known as Wilkie's syndrome, cast syndrome, or aorto-mesenteric compass syndrome) is an obstruction of the duodenum caused by extrinsic compression between the SMA and the aorta. The median age of patients is 23 years old (range 0-91 years old) and predominant in females over males with a ratio of 3:2. The symptoms are variable, consisting of postprandial abdominal pain, nausea and vomiting, early satiety, anorexia, and weight loss and can mimic anorexia nervosa or functional dyspepsia. Because recurrent vomiting leads to aspiration pneumonia or respiratory depression via metabolic alkalosis, early diagnosis is required. The useful diagnostic modalities are computed tomography as a standard tool and ultrasonography, which has advantages in safety and capability of real-time assessments of SMA mobility and duodenum passage. The initial treatment is usually conservative, including postural change, gastroduodenal decompression, and nutrient management (success rates: 70%-80%). If conservative therapy fails, surgical treatment (i.e., laparoscopic duodenojejunostomy) is recommended (success rates: 80%-100%).

Keywords: Superior mesenteric artery syndrome, Wilkie’s syndrome, Cast syndrome, Aorto-mesenteric compass syndrome

Core Tip: To summarize, superior mesenteric artery syndrome (SMAS) is a rare condition that occurs when the superior mesenteric artery compresses the third part of the duodenum. This compression can cause obstructive symptoms and weight loss. SMAS can be caused by a variety of factors, including abnormal anatomy, rapid weight loss, and previous abdominal surgery. It is most commonly seen in young, thin females, but can occur in males and people of any age or body type. Treatment may involve dietary modifications, medications, and surgery to correct the underlying cause. If left untreated, SMAS can lead to serious complications, including malnutrition and intestinal damage.